Cabaletta Bio (CABA) EPS (Weighted Average and Diluted) (2021 - 2025)
Cabaletta Bio (CABA) recorded quarterly EPS (Weighted Average and Diluted) of -$0.35 in Q4 2025, up 20.45% quarter-over-quarter from -$0.44 in Q3 2025, and up 46.15% on a YoY basis from -$0.24 in Q4 2024.
Cabaletta Bio (CABA) EPS (Weighted Average and Diluted) (2021 - 2025) Analysis & Trends
Cabaletta Bio's EPS (Weighted Average and Diluted) history runs 5 years deep, the most recent figure standing at -$0.35 for Q4 2025.
- In Q4 2025, EPS (Weighted Average and Diluted) rose 46.15% year-over-year to -$0.35; the TTM figure through Dec 2025 stood at -$2.23 (up 4.7% YoY), while the FY2025 annual figure was -$2.1, up 10.26% from the prior year.
- EPS (Weighted Average and Diluted) was -$0.35 for Q4 2025 at Cabaletta Bio, up from -$0.44 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.35 in Q4 2025 to a low of -$0.73 in Q2 2025.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.5 across 5 years, with a median of -$0.45 in 2021.
- The sharpest annual moves came in 2024 and 2025: EPS (Weighted Average and Diluted) slumped 67.57% in 2024, then soared 46.15% in 2025.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.49 in 2021, then slipped by 6.12% to -$0.52 in 2022, then climbed by 9.62% to -$0.47 in 2023, then sank by 38.3% to -$0.65 in 2024, then jumped by 46.15% to -$0.35 in 2025.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.35 (Q4 2025), -$0.44 (Q3 2025), and -$0.73 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.61 |
| 10 | Cabaletta Bio | 151.84 Mn | 18.24 Mn | - | -0.35 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.35 |
| Sep 30, 2025 | -0.44 |
| Jun 30, 2025 | -0.73 |
| Mar 31, 2025 | -0.71 |
| Dec 31, 2024 | -0.65 |
| Sep 30, 2024 | -0.62 |
| Jun 30, 2024 | -0.56 |
| Mar 31, 2024 | -0.51 |
| Dec 31, 2023 | -0.47 |
| Sep 30, 2023 | -0.37 |
| Jun 30, 2023 | -0.37 |
| Mar 31, 2023 | -0.45 |
| Dec 31, 2022 | -0.52 |
| Sep 30, 2022 | -0.39 |
| Jun 30, 2022 | -0.45 |
| Mar 31, 2022 | -0.45 |
| Dec 31, 2021 | -0.49 |
| Sep 30, 2021 | -0.45 |
| Jun 30, 2021 | -0.45 |